Amyris

Croda Partners on Vaccine Adjuvants

UK specialty chemicals company Croda has signed partnership agreements with US companies Amyris and Botanical Solutions Inc (BSI) to source sustainable vaccine adjuvants.

Amyris and ImmunityBio Form Covid-19 JV

US biotech Amyris has formed a 50:50 joint venture with compatriot clinical-stage immunotherapy firm ImmunityBio to accelerate the commercialization of a next-generation Covid-19 vaccine. The companies signed a binding agreement for the venture last November.

Amyris Scales up Cannabinoid Process

Synthetic biotech company Amyris said it has successfully scaled up commercial production of cannabigerol (CBG) through leveraging its industrial fermentation process capability. The precursor from which all other cannabinoids are synthesized, CBG is a non-psychoactive cannabinoid that is said to present significant therapeutic potential.

ADL and Amyris Extend Production Pact Again

Along the Acquisition Trail

DSM Buys Amyris Brasil for $58 Million

DSM and Amyris Expand Cooperation

DSM Takes Stake in Amyris

Amyris and Nikkol in Cosmetic Ingredients Pact

Amyris Extends Farnesene Pact with Kuraray

Amyris Signs new Nutraceuticals Pact

Braskem Joins Amyris and Michelin in Renewable Isoprene R&D

AOCS World Conference on Fabric and Home Care

Biofuel Maker Solazyme Shares Rise in Nasdaq Debut